[1]Flores-Mendoza G, Sanson SP, Rodriguez-Castro S, et al. Mechanisms of tissue injury in lupus nephritis[J]. Trends Mol Med, 2018, 24:364-378. [2]罗晨曦, 谭长强. CD4+CD25+调节性T细胞与自身免疫性疾病研究进展[J]. 医学诊断, 2015, 5:21-27. [3]Kim HR, Kie JH, Lim W, et al. CD4(+)CD25(+) regulatory T cells from MRL/lpr mice were functionally more active in vitro but did not prevent spontaneous as well as adriamycin-induced nephropathy in vivo[J]. Rheumatology, 2012, 51:1357-1367. [4]Liang CL, Lu W, Zhou JY, et al. Mangiferin Attenuates Murine Lupus Nephritis by Inducing CD4+Foxp3+ Regulatory T Cells via Suppression of mTOR Signaling[J]. Am J Transl Res, 2018, 50:1560-1573. [5]Bao R, Hou J, Li Y, et al. Adenosine promotes Foxp3 expression in Treg cells in sepsis model by activating JNK/AP-1 pathway[J]. Am J Transl Res, 2016, 8:2284-2292. [6]Liu MF, Wang CR, Fung LL, et al. Decreased CD4+CD25+ T cells in peripheral blood of patients with systemic lupus erythematosus[J]. Scand J Immunol, 2004, 59:198-202. [7]赵宏丽, 赵俊芳. 系统性红斑狼疮患者CD4+CD25+调节性T细胞及其细胞因子的改变[J]. 中国皮肤性病学杂志, 2012:581-583. [8]Wang Y, Zhang H, He H, et al. LRCH1 suppresses migration of CD4(+) T cells and refers to disease activity in ulcerative colitis[J]. Int J Med Sci, 2020, 17:599-608. [9]Liu C, Xu X, Han L, et al. LRCH1 deficiency enhances LAT signalosome formation and CD8(+) T cell responses against tumors and pathogens[J]. Prac Natl Acad Sci U S A, 2020, 117:19388-19398. [10]Chuck MI, Zhu M, Shen S, et al. The role of the LAT-PLC-gamma1 interaction in T regulatory cell function[J]. J Immunol, 2010, 184:2476-2486. |